Hopp til innhold

Project

Buprenorphine versus methadone for pregnant women in opioid maintenance treatment (OMT) - project description

Published Updated

We will systematically summarise research on short- and long-term effects for mother, foetus and child of buprenorphine- versus methadone-based maintenance treatment during pregnancy.


Summary

It is unclear whether opioid dependent women in fertile age should be recommended buprenorphine or methadone when they enter opioid maintenance treatment (OMT). We will systematically summarise research on short- and long-term effects for mother, foetus and child of buprenorphine- versus methadone-based maintenance treatment during pregnancy.

See the full project description at Cristin for more information about results, researchers, contact information etc.

Project participants

Project leader

Hege Kornør, Avdeling for vurdering av tiltak, Norwegian Institute of Public Health

Project participants

Hilde Strømme, Avdeling for vurdering av tiltak, Norwegian Institute of Public Health
Kristin Thuve Dahm, Avdeling for vurdering av tiltak, Norwegian Institute of Public Health

About this prosjektet